The purpose of the study:

To evaluate how safe and effective an investigational medication will be as a possible Lupus treatment, when compared with placebo (inactive substance). Participants may be able to continue taking stable doses of some standard lupus medications.

Duration:

Up to 1 year

Number of visits:

18-22 visits

Compensation:

Up to $1090

Qualifications and Notes: 

Qualified participants must be 18 yrs of age or older and have been diagnosed with SLE (Systemic Lupus Erythematosus).